Expanding Options for Relapsed/Refractory HER2+ Metastatic Breast Cancer

July 7, 2020
Targeted Oncology

Dr Mark Pegram and Dr Julie Gralow discuss treatment options in relapsed/refractory HER2+ metastatic breast cancer.